WTW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WTW is not a good buy right now for an impatient investor. Price action is weakening (MACD still negative, RSI ~37), the stock is sitting below the key pivot (320.68) and closer to support (313.66), and pattern-based odds skew modestly negative over the next day/week/month. Options positioning is mildly constructive but thin, and there are no Intellectia proprietary buy signals today. With earnings (QDEC 2025) on 2026-02-03 pre-market, near-term direction is likely catalyst-driven rather than a clean technical uptrend—so the risk/reward today is not attractive for an immediate entry.
Trend/price context: WTW closed at 317.45, below the pivot level 320.68, implying near-term control remains with sellers unless it reclaims that level. Momentum: MACD histogram is -1.355 (below zero), though “negatively contracting” suggests downside momentum is easing but not reversed. RSI: RSI(6) at 37.5 is weak/near-oversold territory (bearish-to-neutral), consistent with a recent pullback rather than a fresh breakout. Moving averages: Converging MAs point to consolidation after weakness—typically a “wait for confirmation” setup, not an urgent buy. Levels: Support S1 313.66 (then S2 309.32). Resistance R1 327.70 (then R2 332.04). A stronger long entry setup would usually involve reclaiming the pivot/clearing 327.70. Quant/pattern read: Similar-pattern stats indicate ~50% probability of a -1.74% next day move, -2.04% next week, and -2.35% next month—tilting against buying immediately.
Intellectia Proprietary Trading Signals
Product/news momentum: Willis launched an 8-point digital infrastructure risk management framework and is targeting large, growing insurance spend tied to data centers (industry premium opportunity referenced as potentially reaching $10B).
Business development: Tailored digital infrastructure solutions and claims of targeting >$3B in insurance capacity for hyperscale projects could support longer-term brokerage growth.
Analyst support: Multiple firms maintain Buy/Outperform/Overweight ratings with price targets well above the current price (mid-$300s to high-$380s).
on 2026-02-03 pre-market can drive a gap move; current chart does not show a clear upside trend into the event.
Latest quarter: 2025/Q3. Growth trend: Revenue was essentially flat/slightly down YoY (-0.04% to ~$2.288B). Profitability metrics in the snapshot show a sharp decline (Net Income and EPS down over 100% YoY), which signals either significant one-time impacts and/or margin pressure in the period. Overall, the provided quarter data does not show clean accelerating growth heading into the next earnings report.
Recent trend: Price targets have generally been nudged higher or reaffirmed in early Jan 2026 (e.g., Barclays to $318 from $303 but still Underweight; Goldman to $375; KBW to $388; BofA to $340 Neutral), while some firms have made modest cuts (Evercore down slightly to $383; Wells Fargo down to $356). Wall Street pros: Majority bullish/constructive ratings (Buy/Outperform/Overweight) with targets implying meaningful upside vs 317, suggesting confidence in longer-term earnings power and brokerage positioning. Wall Street cons: The notable bear case (Barclays Underweight) centers on softening pricing and broker organic growth headwinds; even some neutrals highlight fundamentals “tipping the wrong direction” in parts of P&C pricing and loss-cost dynamics.
